This research was funded by grants from the National Institutes of Health (R01HL113601, R01HL128072, and R01HL130840 to M. Mercola; R44ES023521 to A.C.; P30 AR06130303 to M. Mercola, A.S., and P.L.P.; R01AR056712 and R01AR052779 to P.L.P.; and F31 AR065923-01 to M.T.), the Muscular Dystrophy Association (200845 to A.S.), the Fondation Leducq Transatlantic Alliance (Shapeheart), and the California Institute for Regenerative Medicine (CIRM; RC1-000132 to M. Mercola). S.A. was supported by the CIRM post-doctoral training program (TG2-01162).